Lind Kevin Robert bought AVTX
March 31, 2026 · Form 4 insider transaction
Lind Kevin Robert bought 1,370 shares of Avalo Therapeutics, Inc. at $12.13 per share, a transaction worth $16.6K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
1,370
Price
$12.13
Total value
$16.6K
InsiderLind Kevin Robert
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 31, 2026
Filing dateApril 1, 2026
Shares owned after1,370
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options were granted on March 31, 2026, and are 100% vested.